![]() |
市场调查报告书
商品编码
1828141
2025年全球雷射动脉粥状硬化斑块切除术设备市场报告Laser Atherectomy Devices Global Market Report 2025 |
近年来,雷射动脉粥状硬化斑块切除术设备市场呈现强劲成长势头,市场规模从2024年的12.2亿美元成长至2025年的13亿美元,复合年增长率达6.3%。这段时期的成长归因于心血管疾病发生率的上升、复杂病变的治疗、微创手术的普及、设备设计的改进、临床证据的累积以及有效性的提升。
预计未来几年,雷射动脉粥状硬化斑块切除术设备市场规模将强劲成长,2029年将达到18.2亿美元,复合年增长率为8.8%。预测期内的增长归因于对微创手术的需求、心血管疾病的增加、监管核准的不断扩大、设备安全性和效率的提高以及医生培训项目的推进。预测期内的主要趋势包括以患者为中心的护理、设备小型化和便携性、个人化治疗方法、影像技术的整合以及对安全性和有效性的关注。
雷射动脉粥状硬化斑块切除术仪是医疗设备。这类设备通常用于治疗周边动脉疾病(PAD) 和动脉粥状硬化等疾病,这些疾病是由于斑块中斑块的积聚导致血管狭窄或阻塞。雷射动脉粥状硬化斑块切除术仪使用高能量雷射光束汽化斑块,使清除阻塞物变得更容易。
雷射动脉粥状硬化斑块切除术设备主要分为两种:电脑控制和非电脑控制。电脑控制是指使用电脑技术来管理和控制各种系统和流程。这类设备用于医院、外科中心、门诊手术中心和其他医疗机构的心血管、週边血管和神经血管手术。
2025年春季美国关税的突然上调及其引发的贸易摩擦对医疗设备产业产生了重大影响,尤其对影像处理设备、手术用不銹钢和一次性塑胶等进口零件产生了重大影响。由于医院和诊所抵制涨价,製造商面临利润压力。监管挑战使情况更加复杂,因为由于关税而更换供应商通常需要医疗设备重新认证,导致市场进入延迟。为此,企业正在透过双重采购关键零件、增加标准化产品的国内生产以及加快寻找更具成本效益的材料来降低风险。
本研究报告是商业研究公司(The Business Research Company)新报告系列的一部分,该系列提供激光动脉粥样动脉粥状硬化斑块切除术动脉粥状硬化斑块切除术设备市场统计数据,例如全球市场规模、区域份额、竞争对手的市场份额、详细的激光动脉粥状硬化斑块切除术粥样硬化斑块切除术设备细分市场、市场趋势和商业机会,以及您在激光动脉粥样硬化动脉粥状硬化斑块切除术术设备行业取得成功所需的数据。这份雷射动脉粥状动脉粥状硬化斑块切除术术设备市场研究报告对该行业的现状和未来情况进行了详细分析,为您提供所需的一切资讯的完整观点。
未来五年8.8%的预测成长率,较我们先前对该市场的预测略有下降0.2%。下降主要源自于美国与其他国家之间关税的影响。美国可能会直接感受到这种影响,例如对来自荷兰和台湾等主要地区的光纤雷射导管和生理食盐水冲洗系统征收关税,这可能导致周边动脉手术延迟,并增加血管介入治疗的成本。此外,这种影响可能会透过互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响,在更广泛的层面上显现。
动脉粥状硬化盛行率的不断上升预计将推动雷射粥状动脉粥状硬化斑块切除术设备市场的成长。动脉粥状硬化是一种以动脉中脂肪沉积物堆积为特征的疾病,会导致动脉变窄和硬化。这会阻碍血液流向重要器官和组织,从而引发严重的健康併发症,如心臟病、中风和周边动脉疾病。雷射粥样动脉粥状硬化斑块切除术术设备透过雷射汽化斑块,然后透过导管将其从体内移除来治疗动脉硬化。例如,根据英国倡议提高医疗品质的哨兵中风国家审计计划,2023 年 3 月,2022/23 年有 91,162 例中风住院治疗,比 2021/22 年的 92,054 例略有下降。因此,动脉粥状硬化盛行率的不断上升是推动雷射粥状动脉粥状硬化斑块切除术设备市场成长的关键因素。
由于心血管疾病 (CVD) 盛行率的上升,雷射动脉粥状硬化斑块切除术设备市场预计也将成长。 CVD 包括影响心臟和血管、影响循环系统的疾病。心血管疾病的激增导致需要治疗动脉阻塞和动脉粥状硬化斑块的患者数量增加,对雷射动脉粥状动脉粥状硬化斑块切除术设备的需求量很高。 2022 年 8 月,美国心臟学会预测,糖尿病、血脂异常症、高血压和肥胖症将会增加,导致 2025 年至 2060 年间美国所有四种心血管危险因子都会增加。报告强调,预计中风、心臟衰竭、缺血性心臟疾病和心臟病发作将显着增加。因此,心血管疾病的增加正在推动雷射动脉粥动脉粥状硬化斑块切除术设备市场的发展。
为了满足更广泛的客户群、增加销售额和提高整体收益,雷射动脉粥状硬化斑块切除术设备市场的主要企业正在积极创新,以创造先进的产品,包括动脉粥状硬化斑块切除系统。动脉粥状硬化斑块切除术斑块切除医疗设备就是这种趋势的一个例子,它是专门设计用于去除血管中动脉粥状硬化斑块的医疗设备。例如,2022 年 8 月,美国医疗设备公司 AngioDynamics Inc. 宣布其 Auryon 动脉粥状硬化斑块切除系统已获得美国食品药物管理局(FDA) 的扩大标籤批准。 Auryon 动脉粥状硬化动脉粥状硬化斑块切除术系统因其有效治疗各种类型鼠蹊部病变的能力而闻名,包括膝上 (ATK)、膝下 (BTK) 和支架内血管再阻塞(ISR)。该系统配备最尖端科技,可为动脉阻塞提供强有力的治疗。它是一种先进的雷射旋切系统,可有效治疗任何类型、长度和位置的病变,同时最大限度地减少对血管壁的影响。
雷射动脉动脉粥状硬化斑块切除术设备市场的主要企业也专注于开发先进的解决方案,例如动脉粥状硬化斑块切除平台,以满足更大基本客群的需求,推动更多销售,并增加收益。动脉粥状硬化斑块动脉粥状硬化斑块切除术平台是一个综合系统或一套工具,旨在治疗动脉斑块状硬化,这是一种以动脉斑块堆积为特征的疾病。例如,2023 年 10 月,美国医疗设备公司 CardioFlow Inc. 宣布 FDA 批准其 FreedomFlow 眼眶动脉粥状动脉粥状硬化斑块切除术週边平台。 FreedomFlow 平台采用现代作用机制,专门用于清除下肢动脉的斑块阻塞。此导管的独特设计利用角动量物理学,并结合了五个钻石涂层球体,形成螺旋形状,确保在推进和缩回过程中同时与血管壁接触。此外,钻石涂层尖端有助于驱动轴顺利穿过狭窄的闭塞处。这种创新方法为医生提供了一种高效、有效且适应性强的治疗手段,用于治疗各种血管直径的复杂周边动脉疾病(PAD),从踝部 2 毫米到髋部 8 毫米。此平台功能多样,只需一台装置即可处理同一血管内的多条动脉和多处阻塞。
2023年4月,美国医疗设备製造商雅培实验室(Abbott Laboratories)收购了心血管系统公司(Cardiovascular Systems, Inc.),收购金额未揭露。此策略措施将整合心血管系统公司(CSI)先进的动脉粥状硬化斑块动脉粥状硬化斑块切除术系统,增强雅培治疗血管疾病的能力。该系统旨在为血管成形术和支架置入置入术准备血管,并最终恢復血流。此次收购符合雅培在血管产品组合中更广泛的投资策略,并增强了雅培为周边动脉疾病和冠状动脉疾病患者提供全面护理的能力。心血管系统公司是美国动脉粥状动脉粥状硬化斑块切除术设备製造商,目前隶属于雅培旗下。
雷射动脉粥状硬化斑块切除术设备市场的主要企业包括波士顿科学公司、Terumo Corporation、Medtronic公司、Avinger 公司、心血管系统公司、荷兰皇家飞利浦公司、AngioDynamics 公司、碧迪公司、Eximo Medical 有限公司、康德乐公司、B. Braun SE、CR Bard 公司、雅培实验室、Biotrond SEubampy Ktra、Vakex、Gtraak、Hakak 实验室、BioVOak Fexakex、Hakakex、Gtraak、Hakak) 科公司、Volcano 公司、Atrium Medical 公司、拜耳公司、Biosensors 国际集团有限公司、库克医疗公司、Cordis 公司、Covidien 公司、美敦力血管公司、Shockwave Medical 有限公司、Acotec Scientific Holdings 有限公司、Advanced Catheter Therapies 公司和 ArioMedica 公司和 ArioMedica 有限公司。
2024年,北美是雷射斑块切除术设备市场最大的地区。根据全球雷射斑块动脉粥状硬化斑块切除术术设备市场报告,预测期内亚太地区将成为成长最快的地区。此雷射斑块动脉粥状硬化斑块切除术设备市场报告涵盖亚太地区、西欧、东欧、北美、南美以及中东和非洲。
雷射动脉粥状硬化斑块切除术设备市场报告涵盖的国家有澳洲、巴西、中国、法国、德国、印度、印尼、日本、俄罗斯、韩国、英国、美国、加拿大、义大利、西班牙
雷射动脉粥状硬化斑块切除术设备市场包括 Turbo Elite、Diamondback 360、Phoenix 斑块切除系统、Jetstream 斑块切除系统、HawkOne 系统和 Ocelot 系统的销售。此市场的价值是指“出厂价”,即产品製造商或生产商向其他营业单位(包括下游製造商、批发商、经销商和零售商)或直接向最终客户销售的产品价值。该市场的产品价值还包括产品製造商提供的任何相关服务。
A laser atherectomy device is a medical instrument designed to employ laser energy for breaking down and removing blockages from blood vessels. This device is commonly utilized in the treatment of conditions such as peripheral artery disease (PAD) or atherosclerosis, where plaque buildup in the arteries leads to narrowing or blockages. The laser atherectomy device operates by delivering a high-energy laser beam to the plaque, causing it to vaporize and facilitating the removal of the blockage.
The primary types of laser atherectomy devices include those with computer control and others. Computer control involves the utilization of computer technology to manage and control various systems and processes. These devices find applications in cardiovascular, peripheral vascular, and neurovascular procedures and are employed by hospitals and surgical centers, ambulatory care centers, and other medical facilities.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.
The laser atherectomy devices market research report is one of a series of new reports from The Business Research Company that provides laser atherectomy devices market statistics, including laser atherectomy devices industry global market size, regional shares, competitors with a laser atherectomy devices market share, detailed laser atherectomy devices market segments, market trends and opportunities, and any further data you may need to thrive in the laser atherectomy devices industry. This laser atherectomy devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The laser atherectomy devices market size has grown strongly in recent years. It will grow from $1.22 billion in 2024 to $1.3 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to rise in cardiovascular diseases, treatment of complex lesions, minimally invasive procedures, improvements in device design, clinical evidence and efficacy.
The laser atherectomy devices market size is expected to see strong growth in the next few years. It will grow to $1.82 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to demand for minimally invasive procedures, rise in cardiovascular conditions, expansion of regulatory approvals, advancements in device safety and efficiency, physician training programs. Major trends in the forecast period include patient-centric care, miniaturization and device portability, personalized treatment approaches, integration of imaging technologies, focus on safety and efficacy.
The forecast of 8.8% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on fiber-optic laser catheters and saline flushing systems, sourced from key regions such as the Netherlands and Taiwan, which could lead to postponed peripheral artery treatments and higher costs for vascular interventions.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
An increase in the prevalence of atherosclerosis is anticipated to drive the growth of the laser atherectomy devices market. Atherosclerosis is a medical condition characterized by the accumulation of fat within the arteries, leading to their narrowing and hardening. This can impede blood flow to essential organs and tissues, resulting in severe health complications such as heart disease, stroke, and peripheral artery disease. Laser atherectomy devices are employed in the treatment of atherosclerosis by utilizing a laser to vaporize the plaque, which is subsequently removed from the body via a catheter. For example, in March 2023, the Sentinel Stroke National Audit Programme, a UK-based initiative focused on healthcare quality improvement, reported that there were 91,162 patients hospitalized for stroke in 2022/23, a slight decrease from 92,054 in 2021/22. Thus, the rising prevalence of atherosclerosis is a key factor driving the growth of the laser atherectomy devices market.
The laser atherectomy devices market is also anticipated to witness growth due to the rising incidence of cardiovascular diseases (CVD). CVD encompasses diseases affecting the heart or blood vessels, impacting the circulatory system. The surge in cardiovascular diseases leads to an increased number of patients requiring treatment for arterial occlusions and atherosclerotic plaque, thereby creating a higher demand for laser atherectomy devices. In August 2022, the American College of Cardiology projected an increase in all four cardiovascular risk factors between 2025 and 2060 in the United States, with diabetes, dyslipidemia, hypertension, and obesity on the rise. The report highlighted substantial projected increases in stroke, heart failure, ischemic heart disease, and heart attack rates. Therefore, the growth of cardiovascular diseases propels the laser atherectomy devices market.
Leading companies in the laser atherectomy devices market are actively innovating to create advanced products, including atherectomy systems, to cater to broader customer bases, drive increased sales, and boost overall revenue. An atherectomy system, a medical device specifically crafted for the removal of atherosclerotic plaque from blood vessels, exemplifies this trend. For instance, in August 2022, AngioDynamics Inc., a US-based medical device company, revealed that the Auryon Atherectomy System had received Expanded Indications clearance from the United States Food and Drug Administration (FDA). The notable feature of the Auryon Atherectomy System lies in its capacity to effectively address various infrainguinal lesion types, spanning above-the-knee (ATK), below-the-knee (BTK), and in-stent restenosis (ISR). Employing cutting-edge technology, this system delivers powerful treatment for arterial occlusions. Significantly, it distinguishes itself as a pioneering laser atherectomy system capable of efficiently treating lesions of any type, length, and location with minimal impact on vessel walls.
Prominent companies in the laser atherectomy devices market are also investing efforts in developing advanced solutions, such as atherectomy platforms, to meet the demands of larger customer bases, drive more sales, and enhance revenue. An atherectomy platform constitutes a comprehensive system or set of tools designed for treating atherosclerosis-a medical condition characterized by plaque buildup in arteries. For instance, in October 2023, Cardio Flow Inc., a US-based medical device company, announced FDA clearance for the FreedomFlow, an orbital atherectomy peripheral platform. The distinctive feature of the FreedomFlow platform lies in its contemporary mechanism of action tailored to clear plaque blockages in leg arteries. Its exclusive catheter-based design leverages angular momentum physics, creating a spiral geometry that ensures simultaneous contact with the vessel wall during both advancement and retraction through the incorporation of five diamond-coated spheres. Additionally, a diamond-coated tip facilitates the smooth passage of the driveshaft through narrow blockages. This innovative approach provides physicians with an exceptionally efficient, effective, and adaptable means of treating complex Peripheral Artery Disease (PAD) across a broad spectrum of vessel diameters, ranging from 2 mm in the ankle to 8 mm in the hip. The platform offers greater versatility in addressing multiple arteries and multiple blockages within the same vessel, all achieved with a single device.
In April 2023, Abbott Laboratories, a US-based medical device company, completed the acquisition of Cardiovascular Systems, Inc. for an undisclosed amount. This strategic move enhances Abbott's capabilities to address vascular disease by incorporating CSI's leading atherectomy system designed to prepare vessels for angioplasty or stenting, ultimately restoring blood flow. The acquisition aligns with Abbott's broader investment strategy in its vascular portfolio, fortifying its ability to deliver comprehensive care for patients dealing with peripheral and coronary artery disease. Cardiovascular Systems Inc., a US-based manufacturer of atherectomy devices, now operates as part of Abbott's portfolio.
Major companies operating in the laser atherectomy devices market include Boston Scientific Corporation, Terumo Corporation, Medtronic plc, Avinger Inc., Cardiovascular Systems Inc., Koninklijke Philips N.V., AngioDynamics Inc., Becton, Dickinson and Company, Eximo Medical Ltd., Cardinal Health, B. Braun SE, C. R. Bard Inc., Abbott Laboratories, Biotronik SE & Co. KG, Rex Medical, Spectranetics Corporation, Straub Medical AG, Vascular Solutions Inc., Volcano Corporation, Atrium Medical Corporation, Bayer AG, Biosensors International Group Ltd., Cook Medical LLC, Cordis Corporation, Covidien plc, Medtronic Vascular, Shockwave Medical Inc., Acotec Scientific Holdings Ltd., Advanced Catheter Therapies Inc., ArioMedica Ltd.
North America was the largest region in the laser arthectomy devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global laser atherectomy devices market report during the forecast period. The regions covered in the laser atherectomy devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the laser atherectomy devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The laser atherectomy devices market consists of sales of turbo elite, diamondback 360, phoenix atherectomy system, jetstream atherectomy system, hawkone system, and ocelot system. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Laser Atherectomy Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on laser atherectomy devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for laser atherectomy devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The laser atherectomy devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.